Boehringer Ingelheim (Canada) Ltd.

Canada

1 December 2019 - 30 November 2020

No articles found. Boehringer Ingelheim (Canada) Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.

C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim)

↳ Boehringer Ingelheim International GmbH

↳ Boehringer Ingelheim (Canada) Ltd.

Boehringer Ingelheim Corporation

Boehringer Ingelheim Ltd.

Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim RCV GmbH & Co. KG

Nippon Boehringer Ingelheim Co. Ltd.

Boehringer Ingelheim GmbH

Boehringer Ingelheim Pharma GmbH & Co. KG

Boehringer Ingelheim Vetmedica GmbH

Boehringer Ingelheim Animal Health, Inc.

Boehringer Ingelheim Vetmedica, Inc.

Return to institution outputs

Latest supplement

Nature Index 2021 Asia Pacific

Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region. While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have focused attention on vast opportunities for researchers in countries in close proximity and South and southeast Asia to work more closely together on new initiatives.

Access free